Cardioneuroablation for reflex syncope or functional bradyarrhytmias: new insight from a single center experience
Open Access
- 13 January 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 11, 1526825
Abstract
Background: Cardioneuroablation (CNA) is a new approach to treat reflex syncope and functional bradyarrhytmias caused by autonomic imbalance. We report our experience using CNA.Method: From September 2022 to July 2023, we took care of 21 patients (mean age 42 ± 21 years; 62% male) affected by reflex syncope or functional bradyarrhythmias. All patients underwent CNA under conscious sedation targeting the superior and/or inferior paraseptal ganglionated plexus (GPs).Results: Nine patients were affected by vasovagal syncope (VVS) and twelve by functional bradyarrhythmias. In 3 cases (14%) the ablation was performed only on the GPs of the right atrium, while in the remaining 86% of cases we performed biatrial lesions. As regards the acute results, we highlighted an increase in sinus heart rate (12 ± 15 bpm, p = 0.001), a shortening of the PQ interval (−18 ± 18 msec, p < 0.001), a reduction of the correct sinus node recovery times (cSNRT) (−142 ± 204 msec, p = 0.114), a shortening of the AH interval (−31 ± 26 msec, p = 0.008), a reduction of the effective refractory period of the atrio-ventricular node (−156; interquartile range from −30 to −160 msec, p = 0.042) and an increase in the Wencheback point (27 ± 20 bpm, p < 0.001). At follow-up, a single patient, due to persistent symptoms and bradyarrhythmic disorder, underwent permanent pacemaker implantation; no other patient had recurrence of syncope, and all remained persistently asymptomatic.Conclusion: Our results confirm the efficacy and safety of CNA for the treatment of VVS and functional bradyarrhythmias, although further studies are needed to support these findings.Keywords
This publication has 37 references indexed in Scilit:
- Cardioneuroablation for neurally-mediated syncope: Initial experienceHellenic Journal of Cardiology, 2023
- Advantages and pitfalls of selective cardioneuroablation targeting the atrioventricular nodeHeartRhythm Case Reports, 2023
- Selective cardioneuroablation of the posteromedial left ganglionated plexus for drug-resistant swallow syncope with functional atrioventricular blockHeartRhythm Case Reports, 2023
- Quality of life improvement following cardioneuroablation for vasovagal syncope: expected or too early to say?Journal of Interventional Cardiac Electrophysiology, 2023
- Cardioneuroablation: Don’t forget atrioventricular node innervationHeartRhythm Case Reports, 2022
- Carotid sinus syndrome treated by cardioneuroablation: Is sinus node denervation enough? Insights from a syncope recurrence reportHeartRhythm Case Reports, 2022
- Cardioneuroablation: Don’t underestimate the posteromedial left atrial ganglionated plexusHeartRhythm Case Reports, 2022
- Heart rate variability: are you using it properly? Standardisation checklist of proceduresBrazilian Journal of Physical Therapy, 2020
- Heart rate variability2013
- “Cardioneuroablation” – new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablationEP Europace, 2005